you are here:

Eris Lifesciences Ltd.

BSE: 540596 | NSE: ERIS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406M01024 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Sep 24, 16:00
737.00 -8.25 (-1.11%)
Volume
AVERAGE VOLUME
5-Day
5,508
10-Day
6,709
30-Day
6,785
1,656
  • Prev. Close

    745.25

  • Open Price

    750.80

  • Bid Price (Qty.)

    735.00 (2)

  • Offer Price (Qty.)

    736.70 (10)

NSE Live

Sep 24, 15:59
737.05 -9.30 (-1.25%)
Volume
AVERAGE VOLUME
5-Day
57,017
10-Day
81,266
30-Day
70,814
30,598
  • Prev. Close

    746.35

  • Open Price

    754.85

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2020 2019 2018 2017 2016
Quarterly Results of Eris Lifesciences (in Rs. Cr.) Jun '21 Mar '21 Dec '20 Sep '20 Jun '20  
Net Sales/Income from operations 306.30 256.85 281.48 298.38 256.11  
Other Operating Income -- -- 5.65 5.00 5.37  
Total Income From Operations 306.30 256.85 287.13 303.37 261.48  
EXPENDITURE  
Consumption of Raw Materials 24.32 22.09 22.15 29.38 25.81  
Purchase of Traded Goods 14.90 29.82 27.42 25.37 29.04  
Increase/Decrease in Stocks 7.25 -1.84 1.02 -1.02 -10.72  
Power & Fuel -- -- -- -- --  
Employees Cost 58.24 46.35 53.93 54.34 52.39  
depreciat 11.23 10.14 9.24 9.21 9.05  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 79.05 66.41 79.27 75.37 64.94  
P/L Before Other Inc. , Int., Excpt. Items & Tax 111.32 83.88 94.11 110.72 90.96  
Other Income 6.45 2.75 3.43 2.41 1.41  
P/L Before Int., Excpt. Items & Tax 117.76 86.63 97.54 113.13 92.37  
Interest 0.46 0.20 0.17 0.20 0.22  
P/L Before Exceptional Items & Tax 117.30 86.43 97.37 112.94 92.16  
Exceptional Items -- -- -- -- --  
P/L Before Tax 117.30 86.43 97.37 112.94 92.16  
Tax 10.58 17.08 8.74 7.44 5.03  
P/L After Tax from Ordinary Activities 106.72 69.35 88.63 105.49 87.13  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 106.72 69.35 88.63 105.49 87.13  
Equity Share Capital 13.58 13.58 13.58 13.58 13.58  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 7.86 5.11 6.52 7.77 6.42  
Diluted EPS 7.85 5.11 6.52 7.76 6.41  
EPS After Extra Ordinary  
Basic EPS. 7.86 5.11 6.52 7.77 6.42  
Diluted EPS. 7.85 5.11 6.52 7.76 6.41  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

No News.
No News.
No News.
No News.